Supha Pharmachem Ltd. benchmarking: Performance to industry peers

Financial

	Supha Pharmachem	AG Universal	Danube Industries
Operational Metrics
Financials
5 yr Average ROE	38.8 %	14.04 %	5.99 %
5yr average Equity Multiplier	60.3	5.28	3.55
5yr Average Asset Turnover Ratio	1.25	2.14	1.58
5yr Avg Net Profit Margin	0.65 %	1.6 %	1.38 %
Price to Book	0.38	2.13	1.12
P/E	18.64	29.45	22.98
5yr Avg Cash Conversion Cycle	478.33 Days	80.72 Days	96.69 Days
Inventory Days	78.27 Days	39.58 Days	31.14 Days
Days Receivable	694.98 Days	51.37 Days	83.28 Days
Days Payable	156.76 Days	50.63 Days	119.36 Days
5yr Average Interest Coverage Ratio	9.58	2.15	106.77
5yr Avg ROCE	66.83 %	14.34 %	10.05 %
5yr Avg Operating Profit Margin	0.73 %	3.84 %	2.07 %
5 yr average Debt to Equity	6.84	2.6	0.48
5yr CAGR Net Profit	14.55 %	55.41 %	28.37 %
5yr Average Return on Assets	0.69 %	2.84 %	2.12 %
Shareholdings
Promoter Holding	1.13 %	70.64 %	39.93 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.02 %	0.0	5.56 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0